Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRAS | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
mRNA | USP15 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
mRNA | IFNGR1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | ARHGAP22 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | NIPBL | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
mRNA | LAMA1 | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
mRNA | PRR7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | DGKI | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
mRNA | SH3BP1 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
mRNA | MAX | CCLE | pan-cancer | AAC | 0.15 | 0.005 |